FLI1 and neoplasm: Two mechanisms for this oncogenic property of EWS-FLI1 have recently been described: interference with tumor suppressive NOTCH signalling pathway activity through transcriptional regulation of autocrine NOTCH ligand expression [152] and direct interaction with p53 [153].